Pharma MES USA

November 7-8, 2019 | USA

Pharma MES USA provides you with precise insights into new business prospects and technical strategies while offering you the chance to discuss specific roadmaps for the future of manufacturing execution systems.

Spotlight

The aim of this hospital-based retrospective analysis is to estimate the prevalence of Lysosomal Storage Disease (LSDs) in the Eastern Province of Saudi Arabia between 1983 and 2016. A total number of 89 Saudi patients from 43 families were diagnosed with different types of LSDs within this time period.


OTHER PAST CONFERENCES

International Conference and Expo on Toxicology and Applied Pharmacology

June 13-14, 2022 | Italy

Magnus Group extends immense pleasure and honour to invite you to its “International Conference and Expo on Toxicology and Applied Pharmacology" scheduled during June 13-14, 2022 in Rome, Italy.

Pharma Manufacturing Automation 2022

May 17-18, 2022 | USA

As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists

4th Elets Pharma Leadership Summit 2022

May 11, 2022 | USA

The Covid-19 pandemic has brought about an accelerated transformation in the Indian Pharmaceutical sector. With technology engulfing the entire gamut of the pharma universe, the wide-ranging transformations have unlocked new opportunities.

ACCORD 2022 Interdisciplinary Conference on Drug Sciences

May 26-28, 2022 | Poland

The goal of the Interdisciplinary Conference on Drug Sciences, ACCORD 2022, is to integrate scientific and industrial activities that focus on different aspects of drug research. The conference will provide participants with a unique opportunity to examine the broad context of this research, going beyond scientific fields and various disciplines.

Spotlight

The aim of this hospital-based retrospective analysis is to estimate the prevalence of Lysosomal Storage Disease (LSDs) in the Eastern Province of Saudi Arabia between 1983 and 2016. A total number of 89 Saudi patients from 43 families were diagnosed with different types of LSDs within this time period.

resources